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Purpose: Using a candidate-gene approach, a recent case-control study identified a previously unknown association
between  neovascular  age-related  macular  degeneration  (AMD)  and  the  coding  Met72Thr  variant  in  the  pigment
epithelium-derived factor (PEDF) gene in a Taiwan Chinese population. However, a subsequent replication study failed
to see this association in a white European population. We noted an important difference in the sample ascertainment
scheme between these two studies. The original study did not consider findings of indocyanine green (ICG) angiography
for disease classification, which is the only way to obtain a clear image of polypoidal choroidal vasculopathy (PCV)
lesions. This suggests that their cohort might include a considerable amount of PCV, given its high prevalence in the
Chinese population. In contrast, the replication study intentionally excluded PCV from the case cohort on the basis of
ICG angiograms. Therefore, the inconsistent finding might be caused by potential sample heterogeneity between these
two studies. In this respect, this association needed to be examined in a case series of clearly defined individuals with
neovascular AMD and PCV. The aim of this study was to validate the previously reported association of the PEDF
Met72Thr variant in a well characterized Japanese population with neovascular AMD and PCV.
Methods: We genotyped the Met72Thr variant (rs1136287) in 116 patients with neovascular AMD, 140 patients with
PCV, and 189 control participants in a Japanese population. Genotyping was performed using TaqMan technology. We
tested for an association of this variant with neovascular AMD and PCV separately. We also evaluated population
stratification in our study cohort.
Results: We found no statistically significant evidence for association between rs1136287 and either neovascular AMD
or PCV under any genetic models (trend, genotypic, dominant, and recessive genetic models; p>0.05). Population structure
analyses excluded stratification artifact in our study population.
Conclusions: We report a lack of association between the PEDF Met72Thr variant and either neovascular AMD or PCV
in a Japanese population. We conclude that the Met72Thr variant does not play a significant role in the risk of developing
neovascular AMD or PCV.
Age-related  macular  degeneration  (AMD),  a  leading
cause  of  blindness  among  older  individuals  in  developed
countries  [1],  is  a  heterogeneous  group  of  disorders  with
variable clinical findings [2]. It manifests at an early stage with
large  drusen  and  pigmentary  abnormalities  in  the  retinal
pigment epithelium at the macula. With progression to an
advanced  stage,  it  presents  with  geographic  atrophy  (dry
AMD) or exudative maculopathy (wet/neovascular AMD) as
the sequela of choroidal neovascularization (CNV).
Inner choroidal vascular networks ending in polypoidal
lesions  are  the  defining  feature  of  polypoidal  choroidal
vasculopathy (PCV) [3-5], which is now clinically classified
into  a  specific  type  of  AMD  [6].  Some  clinical  and
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pathological  features  such  as  demography  [7],  pathology
[8-10],  and  manifestation  [7]  are  common  between
neovascular AMD and PCV; however, important differences
are also noted in clinical behavior [3], histopathology [11,
12], and response to therapy [13,14]. These commonalities
and differences have been a source of much debate as to
whether PCV has a common etiology with neovascular AMD
or a distinct phenotype reflecting a different etiology [8-12,
15].  PCV  has  a  particularly  high  incidence  in  Asian
populations, accounting for 54.7% of patients with findings
suggestive of neovascular AMD in the Japanese population
[7] and 24.5% in the Chinese population [16], in contrast to
only 8 to 13% in European populations [3]. The phenotypic
spectrum of AMD is quite heterogeneous among different
ethnicities.  Dry  AMD  is  more  frequent  in  European
populations than in Asians; the reverse is true for neovascular
AMD [17-19].
To date, many studies have reported various gene variants
associated with AMD [20,21]. However, findings from most
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1107studies have been largely inconclusive because of a lack of
consistent  replication  [20,21].  Thus  far,  variants  in  two
genomic regions have been consistently reproducible across
multiple ethnic groups, including the complement factor H
(CFH) gene at chromosome 1q32 [22-26] and the ARMS2
(LOC387715)/HTRA1 locus at 10q26 [27-30]. These two loci
are associated with all phenotypes of AMD, including early
AMD, dry AMD, and neovascular AMD [25,27]. Genetic
susceptibility to PCV is also strongly associated with the CFH
gene and the ARMS2/HTRA1 locus [31,32], thus indicating
that  these  two  loci  play  a  general  role  in  the  etiology  of
variable phenotypes of AMD and PCV. Besides these shared
genetic  associations,  two  phenotype-specific  associations
have been found. These associations are common variants in
the  elastin  gene  for  PCV  [33]  and  an  allelic  variant
(Leu412Phe) in the toll-like receptor 3 (TLR3) gene for dry
AMD [34]. From the genetic perspective, both general and
phenotype-specific  pathways  may  be  implicated  in  the
pathophysiology  of  AMD  and  PCV.  Therefore,  to  avoid
variable  findings  across  studies,  attention  to  disease
classification is a key aspect of genetic studies on AMD, as
suggested previously [35].
Lin et al. [36] recently reported a previously unknown
association  between  neovascular  AMD  and  the  coding
Met72Thr (rs1136287) variant in the pigment epithelium-
derived factor (PEDF) gene in a Taiwan Chinese population.
The authors reported that the minor allele T of rs1136287 was
significantly associated with increased disease risk, with an
odds ratio (OR) of 3.9 under a recessive disease model [36].
At present, there is no evidence for functional relevance of the
Met72Thr  variant,  nor  has  any  biologic  explanation  been
proposed for this association. Still, there are multiple lines of
evidence for the importance of the protein product PEDF in
the pathogenesis of AMD [37], and thus, PEDF is a reasonable
candidate gene for the disease.
Mattes et al. [38] subsequently failed to replicate this
association in a white European population with neovascular
AMD.  We  noted  an  important  difference  in  the  sample
ascertainment scheme between these two studies [36,38]. Lin
et al. [36] applied consensus criteria for AMD classification
derived  from  analysis  of  a  white  population  and  did  not
consider findings of indocyanine green (ICG) angiography for
disease classification. ICG angiography is the only way to
obtain a clear image of PCV lesions [3]. The work of Lin et
al. suggests that their cohort might include a considerable
amount of PCV, given its high prevalence in the Chinese
population [16]. However, Mattes et al. [38] performed ICG
angiography and excluded individuals with PCV from case
participants.  Since  genetic  susceptibility  to  distinct  AMD
phenotypes seems to be influenced by different genetic factors
[33-35],  genetic  association  studies  on  AMD  can  be
confounded by underlying sample heterogeneity. An example
of this situation can be seen in previous studies on TLR3 for
its  association  with  AMD.  Edwards  et  al.  [39]  examined
polymorphisms  across  TLR  genes,  including  the  TLR3
Leu412Phe variant, in a mixed sample of early AMD, dry
AMD, and neovascular AMD. This analysis was not restricted
to dry AMD, and the authors failed to detect a phenotype-
specific association of TLR3 Leu412Phe with dry AMD. In
contrast, Yang et al. [34] selectively studied subgroups of
subjects with early AMD, dry AMD, and neovascular AMD
and eventually found that the Leu412Phe variant specifically
contributes to the risk of developing dry AMD. Similarly, the
inconsistent finding of the PEDF Met72Thr variant could be
due to potential sample heterogeneity between the studies by
Lin et al. and Mattes et al. Therefore, this association needed
to be examined in a case series of clearly defined individuals
with neovascular AMD and PCV. The aim of this study was
to validate the previously reported association of the PEDF
Met72Thr variant in a well characterized Japanese population
with neovascular AMD and PCV.
METHODS
Study  participants:  This  study  was  approved  by  the
Institutional  Review  Board  at  Kobe  University  Graduate
School of Medicine and was conducted in accordance with the
Declaration  of  Helsinki.  Written  informed  consent  was
obtained  from  all  participants.  All  case  and  control
participants enrolled in this study (more information about
participants in Table 1) were Japanese individuals recruited
from the Department of Ophthalmology at Kobe University
Hospital in Kobe, Japan. This is largely the same sample set
used in our previous studies in which phenotyping criteria
were fully described [31-33,40]. In brief, all our neovascular
AMD  and  PCV  subjects  underwent  comprehensive
ophthalmic examinations, including ICG angiography, and
were  defined  as  individuals  with  angiographically  well
delineated lesions of CNV or PCV. Patients with secondary
choroidal neovascular diseases such as degenerative myopia,
idiopathic CNV, ocular trauma, angioid streaks, and presumed
ocular histoplasmosis were excluded from the recruitment.
The control participants, who were not related to the case
participants,  were  defined  as  individuals  without  macular
degeneration  and  changes  such  as  drusen  or  pigment
abnormalities,  and  thus,  were  categorized  as  having  the
clinical age-related maculopathy staging system stage 1 [41].
Genotyping: Genomic DNA was extracted from peripheral
blood immediately after it was drawn. We genotyped the
Met72Thr  variant  (rs1136287)  using  TaqMan®  SNP
Genotyping Assays (Assay ID: C___1841779_20; Applied
Biosystems, Foster City, CA) on a StepOnePlus™ Real-Time
PCR system (Applied Biosystems), in accordance with the
manufacturer’s instructions. For verification, a random 10%
of  samples  were  genotyped  twice,  yielding  100%
concordance.
Statistical analysis: Testing for association was performed
using software packages SNPGWA v3.02. Deviations from
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the exact test [42] implemented in SNPGWA. We performed
association analyses using the Cochran-Armitage trend test
[43] and genotypic (2 degrees of freedom, χ2 test), dominant
(1 degree of freedom, χ2 test), and recessive (1 degree of
freedom, χ2 test) genetic models. The max(T) permutation
procedure  implemented  in  PLINK  v1.00  was  used  with
10,000 iterations to obtain empirical p values [44]. To adjust
for  age  and  gender  differences  between  case  and  control
subjects, we conducted logistic regression analyses using JMP
version 6.0.3 software (SAS Institute, Cary, NC), assuming a
multiplicative  codominant  genetic  model  by  fitting  the
number of minor allele carried as an ordinal covariate and age
and  gender  as  continuous  and  categorical  covariates,
respectively.  Power  calculations  were  performed  using
QUANTO version 1.2 [45]. We had full power to detect the
OR reported in the original studies for rs1136287 (OR=3.90
under  a  recessive  genetic  model)  at  p<0.05  for  both
neovascular AMD and PCV. Assuming an additive genetic
model, we had 80% power to detect an association of this
variant with ORs ≥1.61 (or ≤0.62) for the neovascular AMD
sample and ≥1.56 (or ≤0.63) for the PCV sample.
Linkage disequilibrium (LD) structures across the PEDF
gene  were  compared  between  Chinese  and  Japanese
populations, using genotype data retrieved from the HapMap
[46] CHB (Han Chinese in Beijing, China) and JPT (Japanese
in Tokyo, Japan) data sets. These retrieved data were loaded
into Haploview [47] to estimate LD parameters and identify
haplotype blocks.
Hidden population stratification in genetic association
studies  can  generate  a  spurious  positive  or  negative
association  [48].  To  prevent  potential  stratification  in  our
study  cohort,  we  evaluated  population  stratification  using
STRUCTURE software [49], as described in previous studies
[40,50,51].  The  following  38  single  nucleotide
polymorphisms  (SNPs),  which  were  randomly  distributed
along the genome and are not in LD with each other (r2<0.04),
were  used  for  stratification  analysis:  rs3818729  (1p13.2),
rs696619 (1p21.3), rs9434 (1p36.12), rs1554286 (1q32.1),
rs13388696  (2p23.1),  rs1042034  (2p24.1),  rs10932613
(2q35),  rs7641926  (3p26.2),  rs2305619  (3q25.32),  rs4074
(4q13.3),  rs6876885  (5p15.1),  rs6459193  (6p11.2),
rs3779109 (7p22.1), rs2227667 (7q22.1), rs6468284 (8p12),
rs10757278  (9p21.3),  rs955220  (9p24.3),  rs1927911
(9q33.1),  rs4838590  (10q11.22),  rs12806  (10q24.2),
rs2019938  (11p15.5),  rs609017  (11q24.3),  rs3912640
(12p13.2),  rs2283299  (12p13.33),  rs715948  (12q13.3),
rs7328193  (13q12.11),  rs1048990  (14q13.2),  rs911669
(14q32.13), rs16948719 (15q22.31), rs11076720 (16q24.3),
rs1051009  (17p13.2),  rs1292033  (17q23.1),  rs7239116
(18q11.2),  rs892115  (19p13.2),  rs3826945  (19p13.3),
rs844906 (20p11.21), rs2825761 (21q21.1), and rs3884935
(22q13.1). The log likelihood of each analysis at a varying
number K (the number of populations) was computed from
three independent runs (20,000 burn-in and 30,000 iterations).
The best estimate of K was defined by calculating posterior
probabilities Pr (K=1, 2, 3, 4, or 5) based on the log likelihood,
as described by Pritchard et al. [52].
RESULTS
A total of 116 patients with neovascular AMD, 140 patients
with PCV, and 189 control participants participated in the
study. Table 1 shows the demographic details of the study
population.  The  PEDF  Met72Thr  (rs1136287)  variant
showed  no  significant  deviation  from  Hardy–Weinberg
equilibrium in the control participants (p=0.66).
Details  of  allele  and  genotype  counts  and  summary
statistics for rs1136287 are shown in Table 2. We found no
statistically  significant  evidence  for  association  between
rs1136287 and either neovascular AMD or PCV under any
genetic models (Table 2). Adjusting for age and gender by
logistic regression analyses did not affect the conclusion (age-
and sex-adjusted p=0.59 for neovascular AMD; age- and sex-
adjusted p=0.33 for PCV, under a multiplicative codominant
model).
We also explored the possibility that failure to replicate
the  previously  reported  association  could  arise  due  to
differences in LD structure between Chinese and Japanese
populations—i.e., if the Met72Thr variant is only a proxy for
some other true causative variant, the inconsistency may be
due to a difference in LD for a pair of the Met72Thr and causal
variants between Chinese and Japanese populations. To this
end,  we  compared  LD  structures  across  the  PEDF  gene
between Chinese and Japanese populations, using genotype
TABLE 1. CHARACTERISTICS OF THE STUDY POPULATION
  Neovascular AMD PCV Controls
Number of participants 116 140 189
Males (%) 78 77 60
Mean age±SD (years) 75±7.2 73±6.9 72±5.8
Age range (years) 57–91 57–86 56–95
A total of 116 patients with neovascular AMD, 140 patients with PCV, and 189 control participants were enrolled in the present
study.  The gender breakdown, mean age, and age range of each population are shown. Abbreviations: age-related macular
degeneration (AMD); polypoidal choroidal vasculopathy (PCV); standard deviation (SD).
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This analysis revealed that the HapMap Chinese (CHB) and
Japanese (JPT) populations are highly similar with regard to
LD pattern and structure of LD blocks across the PEDF gene
(Figure 1).
Next, we examined SNPs within PEDF in an available
data  set,  the  NEI/NCBI  dbGAP  database.  This  database
provides results of genome-wide association analysis for 395
individuals with AMD and 198 controls from the National Eye
Institute  Age-Related  Eye  Disease  Study  (AREDS).  This
genome-wide  association  study  investigated  seven  PEDF
SNPs, including the SNP rs1136287 (Met72Thr) tested here
and  six  other  SNPs  (rs8074840,  rs4274474,  rs2269344,
rs3891224,  rs2071021,  and  rs6828).  None  of  these  seven
SNPs  showed  significant  association  with  AMD  in  this
analysis (p>0.05).
Hidden  population  stratification  between  case  and
control subjects can be a confounding factor yielding false-
positive  or  false-negative  findings  [48].  Population
stratification was examined by STRUCTURE [49], using 38
unlinked  genome-wide  SNPs.  We  found  no  evidence  of
stratification in our study cohort, using the formula;
Pr (K = 1 >  0.99),
thus indicating that our results did not arise from population
stratification.
DISCUSSION
To  validate  the  recently  reported  association  between  the
PEDF Met72Thr variant and wet AMD in a Taiwan Chinese
population [36], we analyzed this variant in Japanese subjects
with  neovascular  AMD  and  PCV  separately,  given  the
possibility that a case population of the original report might
be a mixed sample of neovascular AMD and PCV. Despite
sufficient  power  to  replicate  the  originally  reported
association, we found no statistically significant evidence for
association between this variant and either neovascular AMD
or PCV.
PEDF is mainly a secreted 50 kDa glycoprotein that is
found  in  various  ocular  tissues  including  retinal  pigment
epithelium  and  choroid  [53,54].  PEDF  potently  inhibits
angiogenesis and plays a pivotal role in maintaining vascular
quiescence in the eye [54,55]. Specifically, PEDF has been
repeatedly implicated in the pathology of neovascular AMD:
CNV is associated with decreased levels of PEDF in an eye
with neovascular AMD [56,57], PEDF gene transfer in the
eye  inhibits  laser-induced  CNV  growth  and  promotes
regression of established CNV in a murine model [58,59], and
adenoviral vector-mediated intravitreal gene transfer of PEDF
seems to help prevent the growth of CNV in patients with
neovascular AMD [60]. Thus, from a functional perspective,
PEDF  appeared  to  be  a  reasonable  candidate  for  genetic
susceptibility to neovascular AMD.
Disease  heterogeneity  can  result  in  false-positive
reporting or can obscure the existence of true associations.
Population  stratification  can  also  generate  inconsistent
findings across studies, thus yielding false-positive or false-
negative  association.  To  address  these  concerns,  we
performed association analysis for both neovascular AMD
and PCV because of the unclear definition of the disease
phenotype  included  in  the  original  study  [36].  We  also
examined population stratification in our study cohort and
confirmed the lack of stratification. Many other reasons for
irreproducibility of initial positive findings have been cited,
with failure to exclude chance being considered the most
likely explanation for difficulty in replication [61,62]. To
protect against a range of confounding factors and to provide
greater  support  for  a  claim  of  association,  initial  positive
studies should preferably include multiple replication samples
TABLE 2. ALLELE AND GENOTYPE DISTRIBUTIONS OF RS1136287 AND THE RESULTS OF ASSOCIATION TESTS
Status Genotype                                 Allele OR trend*
(95% CI)
p values (empirical p values)
CC CT TT T Recessive
Control     56                   91                   42                  175
 (0.30)             (0.48)              (0.22)             (0.46)
- - -
Neovascular AMD     41                  52                    23                   98                0.86
 (0.35)      (0.45)       (0.20)      (0.42)        (0.62–1.18)
0.34
(0.35)
0.58
(0.58)
0.30
(0.32)
0.62
(0.67)
PCV    32                  78                    30                  138               1.13
(0.23)             (0.56)              (0.21)             (0.49)        (0.83–1.55)
0.44
(0.47)
0.32
(0.31)
0.17
(0.20)
0.86
(0.89)
The trend p values were obtained by the Cochran-Armitage trend test. Genotypic p values were generated by chi-square tests
on 2×3 contingency tables. Tests for the dominant and recessive models were set up as 2×2 contingency table chi-square tests.
The dominant model compared a combination of C/T+T/T genotypes to the homozygous C/C. The recessive model compared
a combination of C/C+C/T to the homozygous T/T. Empirical p values were generated by 10,000 permutation tests, using the
max(T) permutation procedure implemented in PLINK [44]. Asterisk (*) indicates OR trend test. Abbreviations: odds ratio
(OR); confidence interval (CI); age-related macular degeneration (AMD); polypoidal choroidal vasculopathy (PCV).
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-
Trend         Genotype     Dominant[61,62]. However, Lin et al. did not validate their finding in a
second sample, nor did they evaluate potential stratification
in their study cohort [36]. Finally, our inability to replicate the
previously reported association may result from differences
in the structure of LD across the PEDF gene region between
Chinese and Japanese populations. However, examination of
Figure  1.  Linkage  disequilibrium
structure across the pigment epithelium-
derived  factor  gene  in  Chinese  and
Japanese  populations.  Genotype  data
were retrieved from HapMap CHB (Han
Chinese in Beijing, China; A) and JPT
(Japanese in Tokyo, Japan; B) data sets,
and  linkage  disequilibrium  (LD)
patterns were assessed using Haploview
software [47]. Haplotype blocks were
determined  using  the  “four-gamete
rule” option in this software. Each box
provides  estimated  statistics  of  the
coefficient of determination (r2), with
darker shades representing stronger LD.
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Japanese populations are similar in LD pattern and structure
of LD blocks across the PEDF gene (Figure 1). Mattes et al.
also [38] failed to replicate the original finding of Lin et al.
[36]. Additional support of our negative findings comes from
the genome-wide association study on the AREDS cohort.
Our  experience  highlights  the  importance  of  replication
efforts  in  genetic  association  studies  of  complex  human
diseases.
In conclusion, we report a lack of association between the
PEDF Met72Thr variant and either neovascular AMD or PCV
in a Japanese population. We conclude that the Met72Thr
variant does not play a significant role in the risk of developing
neovascular AMD or PCV.
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